These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 29952638)

  • 1. Anesthetic Management of the Hypertensive Patient: Part I.
    Yancey R
    Anesth Prog; 2018; 65(2):131-138. PubMed ID: 29952638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anesthetic Management of the Hypertensive Patient: Part II.
    Yancey R
    Anesth Prog; 2018; 65(3):206-213. PubMed ID: 30235430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension and anesthesia: cause for concern.
    Cross DA; Collins JR
    South Med J; 1978 Feb; 71(2):161-5. PubMed ID: 341339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To stop or not?
    Mets B
    Anesth Analg; 2015 Jun; 120(6):1413-9. PubMed ID: 25988640
    [No Abstract]   [Full Text] [Related]  

  • 5. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The patient with hypertension undergoing surgery.
    Lapage KG; Wouters PF
    Curr Opin Anaesthesiol; 2016 Jun; 29(3):397-402. PubMed ID: 27031792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unsuccessfully Treated Hypertension: A Major Public Health Problem With a Potential Solution.
    Furberg CD; Sealey JE; Blumenfeld JD
    Am J Hypertens; 2017 Sep; 30(9):857-860. PubMed ID: 28482060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of high-risk hypertensive patients with diabetes: potential role of angiotensin II receptor antagonists.
    Weber MA; Weir MR
    J Clin Hypertens (Greenwich); 2001; 3(4):225-35. PubMed ID: 11498653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy for hypertension.
    Kaplan NM
    Nat Rev Cardiol; 2009 Apr; 6(4):270-1. PubMed ID: 19352329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Beta-Blockers in the Treatment of Hypertension.
    Cruickshank JM
    Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fixed-dose combination therapy in hypertension: pros.
    Taddei S
    High Blood Press Cardiovasc Prev; 2012 Jun; 19(2):55-7. PubMed ID: 22867090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.
    Thomas GN; Chan P; Tomlinson B
    Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension management in an outpatient clinic at the Institute of Cardiology of Abidjan (Ivory Coast).
    Kramoh EK; N'goran YN; Aké-Traboulsi E; Anzouan-Kacou JB; Konin CK; Coulibaly I; Traoré F; Agbechi YM; Guikahue MK
    Arch Cardiovasc Dis; 2011 Nov; 104(11):558-64. PubMed ID: 22117907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of antihypertensive class on intraoperative pressor requirements during carotid endarterectomy.
    Anastasian ZH; Gaudet JG; Connolly ES; Arunajadai S; Heyer EJ
    Anesth Analg; 2011 Jun; 112(6):1452-60. PubMed ID: 21467553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updates on the treatment of essential hypertension: a summary of AHRQ's comparative effectiveness review of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and direct renin inhibitors.
    Powers B; Greene L; Balfe LM
    J Manag Care Pharm; 2011 Oct; 17(8 Suppl):S1-14. PubMed ID: 22088101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence.
    Antza C; Stabouli S; Kotsis V
    Vasc Health Risk Manag; 2016; 12():443-451. PubMed ID: 27895487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prior Medications and the Cardiovascular Benefits From Combination Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High-Risk Hypertensive Patients.
    Brook RD; Kaciroti N; Bakris G; Dahlöf B; Pitt B; Velazquez E; Weber M; Zappe DH; Hau T; Jamerson KA
    J Am Heart Assoc; 2018 Jan; 7(1):. PubMed ID: 29301757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis: A Network Meta-Analysis of Randomized, Controlled Trials.
    Shaman AM; Smyth B; Arnott C; Palmer SC; Mihailidou AS; Jardine MJ; Gallagher MP; Perkovic V; Jun M
    Clin J Am Soc Nephrol; 2020 Aug; 15(8):1129-1138. PubMed ID: 32675281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic.
    Volpe M; Tocci G
    Vasc Health Risk Manag; 2012; 8():371-80. PubMed ID: 22745561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraclass differences among antihypertensive drugs.
    Feldman RD; Hussain Y; Kuyper LM; McAlister FA; Padwal RS; Tobe SW
    Annu Rev Pharmacol Toxicol; 2015; 55():333-52. PubMed ID: 25251994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.